In our most recent round table, Compass Carter Osborne welcomed a cohort of industry leaders to discuss where the next big innovation in the Life Sciences sector is coming from. Addressing a broad range of topics, panelists addressed questions on biotech funding bounce-back; investment appetite in innovative technologies; quantum computing and AI; driving positive outcomes for the sector; and much more. Expertly chaired by CCO Non-Executive Advisor, Geoffrey Dobson, special thanks to all participants for producing an insightful, and engaging session: Matthew Fyfe (STORM Therapeutics Limited), Prashant Shah (o2h discovery ), Dr. Iris Good, Dr. Jerry Wu ([TusPark UK Holdings), Aline Charpentier (Bruntwood SciTech), Sebastian Stachowiak (ICE Biopharma GmbH), Colin Sims (adthera bio), Dr Suhail Nurbhai (Mission Therapeutics), Usman "Oz" Azam (Inspirna, Inc.), Stephen Dowd (Confo Therapeutics), Tarquin Bennett-Coles, Martin Anderson (Carrot Recruitment), Alex Boulger. Access the full report here: https://lnkd.in/eCNunK6v
-
-
-
-
-
+1
